![Richard Giroux](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Giroux
Financieel Directeur/CFO bij
MEIRAGTX HOLDINGS PLC
Vermogen: 14 M $ op 30-06-2026
Profiel
Richard Giroux is Chief Operating Officer & Chief Financial Officer at MeiraGTx UK II Ltd. and MeiraGTx Ireland DAC.
Since 2019, Mr. Giroux is Chief Operating & Financial Officer at MeiraGTx Holdings Plc.
Former roles include Independent Director at Chardan Healthcare Acquisition Corp.
from 2018 to 2019, Independent Director at Chardan Healthcare Acquisition 2 Corp., Partner at Sivik Global Healthcare LLC from 2001 to 2008, Partner at Sarissa Capital Management LP from 2014 to 2015, and Partner at Meadowvale Partners Capital Management LLC from 2010 to 2012.
Education includes undergraduate studies at Yale University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 25-06-2026 | 1.054.682 ( 1,14% ) | 14 M $ | 30-06-2026 |
Actieve functies van Richard Giroux
| Bedrijven | Functie | Begin |
|---|---|---|
| MEIRAGTX HOLDINGS PLC | Financieel Directeur/CFO | 16-04-2019 |
MeiraGTx UK II Ltd.
 MeiraGTx UK II Ltd. Pharmaceuticals: MajorHealth Technology Develops novel gene-based therapies for retinal disorders that lead to vision loss | Financieel Directeur/CFO | - |
MeiraGTx Ireland DAC | Financieel Directeur/CFO | - |
Eerdere bekende functies van Richard Giroux
| Bedrijven | Functie | Einde |
|---|---|---|
| CHARDAN HEALTHCARE ACQUISITION CORP | Directeur/Bestuurslid | 01-10-2019 |
Sarissa Capital Management LP
 Sarissa Capital Management LP Investment ManagersFinance Sarissa seeks to achieve superior risk-adjusted returns by constructing a portfolio, primarily across healthcare and related sectors, where there is a significant discrepancy between market value and intrinsic value. They frequently use activism to close this discrepancy. The firm employs a fundamental, research-driven, value-oriented approach to identify potential investments. They conduct rigorous, fundamentals-based research. Sarissa is an activist firm and is included in SharkWatch50 as one of the 50 most prominent and impactful activist investors. | Corporate Officer/Principal | 01-03-2015 |
Meadowvale Partners Capital Management LLC
 Meadowvale Partners Capital Management LLC Investment ManagersFinance Meadowvale Partners Capital Management manages a multi-manager hedge fund. Portfolios are designed to provide clients' overall portfolios with diversification, low volatility and attractive risk-adjusted returns. | Corporate Officer/Principal | 01-06-2012 |
Sivik Global Healthcare LLC (Old)
 Sivik Global Healthcare LLC (Old) Investment ManagersFinance Sivik invests almost exclusively in US growth stocks in the healthcare technology and services sector without regard to capitalization size. They use a combination top-down, bottom-up approach to find companies with new drugs or technologies and sector dominance or competitive advantages. SIVIK maintains a high turnover | Corporate Officer/Principal | 01-11-2008 |
| RENOVACOR, INC. | Directeur/Bestuurslid | - |
Opleiding van Richard Giroux
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
14
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Sivik Global Healthcare LLC (Old)
Sivik Global Healthcare LLC (Old) Investment ManagersFinance Sivik invests almost exclusively in US growth stocks in the healthcare technology and services sector without regard to capitalization size. They use a combination top-down, bottom-up approach to find companies with new drugs or technologies and sector dominance or competitive advantages. SIVIK maintains a high turnover | Finance |
Sarissa Capital Management LP
Sarissa Capital Management LP Investment ManagersFinance Sarissa seeks to achieve superior risk-adjusted returns by constructing a portfolio, primarily across healthcare and related sectors, where there is a significant discrepancy between market value and intrinsic value. They frequently use activism to close this discrepancy. The firm employs a fundamental, research-driven, value-oriented approach to identify potential investments. They conduct rigorous, fundamentals-based research. Sarissa is an activist firm and is included in SharkWatch50 as one of the 50 most prominent and impactful activist investors. | Finance |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Meadowvale Partners Capital Management LLC
Meadowvale Partners Capital Management LLC Investment ManagersFinance Meadowvale Partners Capital Management manages a multi-manager hedge fund. Portfolios are designed to provide clients' overall portfolios with diversification, low volatility and attractive risk-adjusted returns. | Finance |
MeiraGTx Holdings Plc
 MeiraGTx Holdings Plc BiotechnologyHealth Technology Develops and manufactures genetic medicines | Health Technology |
MeiraGTx UK II Ltd.
MeiraGTx UK II Ltd. Pharmaceuticals: MajorHealth Technology Develops novel gene-based therapies for retinal disorders that lead to vision loss | Health Technology |
Chardan Healthcare Acquisition Corp.
 Chardan Healthcare Acquisition Corp. Financial ConglomeratesFinance Operates as blank check company | Finance |
Chardan Healthcare Acquisition 2 Corp.
 Chardan Healthcare Acquisition 2 Corp. Financial ConglomeratesFinance Operates as blank check company | Finance |
MeiraGTx Ireland DAC |
Kies MarketScreener 
